Header image

Impact Factor Journals
Innate Immune Response in Hypertension.
Current Pharmaceutical Design.
2023,
28(36),
2984-2990,
ISSN: 1381-6128,
PMID: 36154596,
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors.
Archiv der Pharmazie.
2022,
355(12),
e2200419,
ISSN: 0365-6233,
PMID: 36109178,
The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression.
Molecular Medicine Reports.
2022,
26(4),
321,
ISSN: 1791-2997,
PMID: 36043519,
Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana.
Parasitology International.
2022,
91,
102647,
ISSN: 1383-5769,
PMID: 35985636,